» Articles » PMID: 37672026

The ATM-E6AP-MASTL Axis Mediates DNA Damage Checkpoint Recovery

Overview
Journal Elife
Specialty Biology
Date 2023 Sep 6
PMID 37672026
Authors
Affiliations
Soon will be listed here.
Abstract

Checkpoint activation after DNA damage causes a transient cell cycle arrest by suppressing cyclin-dependent kinases (CDKs). However, it remains largely elusive how cell cycle recovery is initiated after DNA damage. In this study, we discovered the upregulated protein level of MASTL kinase hours after DNA damage. MASTL promotes cell cycle progression by preventing PP2A/B55-catalyzed dephosphorylation of CDK substrates. DNA damage-induced MASTL upregulation was caused by decreased protein degradation, and was unique among mitotic kinases. We identified E6AP as the E3 ubiquitin ligase that mediated MASTL degradation. MASTL degradation was inhibited upon DNA damage as a result of the dissociation of E6AP from MASTL. E6AP depletion reduced DNA damage signaling, and promoted cell cycle recovery from the DNA damage checkpoint, in a MASTL-dependent manner. Furthermore, we found that E6AP was phosphorylated at Ser-218 by ATM after DNA damage and that this phosphorylation was required for its dissociation from MASTL, the stabilization of MASTL, and the timely recovery of cell cycle progression. Together, our data revealed that ATM/ATR-dependent signaling, while activating the DNA damage checkpoint, also initiates cell cycle recovery from the arrest. Consequently, this results in a timer-like mechanism that ensures the transient nature of the DNA damage checkpoint.

References
1.
Yoo H, Kumagai A, Shevchenko A, Shevchenko A, Dunphy W . Adaptation of a DNA replication checkpoint response depends upon inactivation of Claspin by the Polo-like kinase. Cell. 2004; 117(5):575-88. DOI: 10.1016/s0092-8674(04)00417-9. View

2.
Wang F, Wang L, Fisher L, Li C, Wang W, Peng A . Phosphatase 1 Nuclear Targeting Subunit (PNUTS) Regulates Aurora Kinases and Mitotic Progression. Mol Cancer Res. 2018; 17(1):10-19. DOI: 10.1158/1541-7786.MCR-17-0670. View

3.
Shiloh Y . ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 2003; 3(3):155-68. DOI: 10.1038/nrc1011. View

4.
Fatima I, Singh A, Dhawan P . MASTL: A novel therapeutic target for Cancer Malignancy. Cancer Med. 2020; 9(17):6322-6329. PMC: 7476815. DOI: 10.1002/cam4.3141. View

5.
Ciccia A, Elledge S . The DNA damage response: making it safe to play with knives. Mol Cell. 2010; 40(2):179-204. PMC: 2988877. DOI: 10.1016/j.molcel.2010.09.019. View